Posts in Pharmaceutical & Life Sciences

Air Cargo Security: Maintaining Product Quality & Preventing Threats

November 19th, 2019 Posted by Air, Food & Beverage, Pharmaceutical & Life Sciences, Transportation 0 thoughts on “Air Cargo Security: Maintaining Product Quality & Preventing Threats”

Air Cargo Security: Maintaining Product Quality & Preventing Threats

Authors: QProducts & Services Team, Under the Direction of Paul Yadron, Sr. VP of Sales

 

 

 

 

U.S. air cargo supply chain handles more than 50,000 tons of cargo each day, of which 7,500 (15%) is designated for domestic passenger carriers, and the remaining 85% is designated for all-cargo carriers, according to the Transportation Security Administration (TSA). Over the past 3-4 decades, air cargo transport has offered a means by which to expeditiously move cargo from points of production and manufacture to points of distribution and sales.

 

Major events over the last few decades have led to increased security measures for the air cargo supply chain, while also allowing us to learn about possible additional security threats and how to prevent them. The quick transport of products by air is especially important for perishable goods, as a major benefit of shipping goods by air is timing. So how do we secure these threats, and how do we maintain the quality of our products?

 

air cargo plane

 

 

 

What is Air Cargo Security?

 

First and foremost, the air cargo industry consists of a complex distribution network linking manufacturers and shippers to freight forwarders, off-airport freight consolidators, and airport sorting and cargo handling facilities where shipments are loaded on and unloaded from an aircraft. Under the Aviation Transport Security Act of 2004, air cargo is defined as goods, other than baggage or stores, that are transported by aircraft. Items shipped by aircraft generally consist of time-sensitive and high-value commodities. Common examples of air cargo include high-value machine parts and manufacturing equipment, electronic components for manufactured goods, consumer electronics, jewelry, and perishable items such as flowers, fruits, fresh fish, and pharmaceuticals.

 

Air cargo security measures aim to protect cargo from theft, but they also secure cargo against incoming materials such as bombs or drugs. Security is a very critical element of the air cargo supply chain. Regulators, organizations, and the industry overall are working together to further secure the air cargo supply chain while ensuring the flow of commerce.

 

palletized technology

 

Maintaining Air Cargo Product Quality

 

As we discussed, a major benefit to shipping items via air is time. The faster a product can get to its destination, the better. When it comes to food, beverage, and pharmaceuticals, these items cannot last very long in transit as the biggest challenge of keeping perishable products fresh has to do with temperature.  The longer an item stays exposed to high temperatures, the quicker it loses its freshness. We all know that temperature-controlled shipping is critical for delicate materials such as pharmaceuticals, medicines, and food.

 

For the pharmaceutical industry, the IATA (International Air Transport Association) Time and Temperature Sensitive Label became effective July 1st, 2012. This label ensured the integrity of the time and temperature of sensitive healthcare air cargo shipments and also ensured that the air cargo supply chain is prepared to handle the demands of these healthcare shipments. The overall aim is to ensure patient safety through effective cold chain distribution. Therefore, it is imperative that airlines, ground handling agents, and other stakeholders within the supply chain are familiar with the regulations and appearance of the label. It is also imperative that effective cold chain solutions are put into place to secure the successful air transit of healthcare products.

 

Unfortunately, one of the main costs with the transportation of perishable items such as fruit and vegetables is wastage due to spoilage related to inadequate temperature management during transit. Keeping perishable food items cool, cold, frozen, or deep frozen is the only way to guarantee product quality and shelf-life as it arrives at the end of a transportation process. Leveraging the proper cold chain equipment such as palletized technology can increase product shelf-life, increase profits, and reduce food loss.

 

security and protection for air cargo

 

 

Security Threats to Air Cargo

 

In the United States, security of air cargo shipments and international shipments to and from the U.S. is regulated by the Transportation Security Administration (TSA). Security threats can impact product integrity and create safety issues in certain markets. Security threats can damage the product altogether, resulting not only in lost product, but additional costs. Historically, security measuring surrounding all-cargo operations have focused on the threat of hijackings, particularly those that could result in using the aircraft as a weapon of mass destruction. According to the Congressional Research Service, a 1994 incident involved an off-duty FedEx flight engineer who attempted to hijack a FedEx DC-10 aircraft and crash it into the company’s Memphis, TN headquarters. At the time, there was no federal requirement to screen personnel or personal baggage carried aboard cargo aircraft. This particular hijack attempt was unsuccessful; however, the threat still remains in the air cargo industry.

 

Another security threat to air cargo includes the threat of explosives. A long-standing concern for cargo loaded on passenger aircraft, several incidents have shown that U.S. bound air cargo shipments are targeted. For instance, the Congressional Research Service reports that on October 29, 2010, intelligence and law enforcement agencies in Dubai, United Arab Emirates, and in the United Kingdom discovered explosive devices concealed in packages shipped as air cargo bound for the United States. Authorities in the U.S. were able to bring down the aircraft; however, the details of this incident highlighted a number of specific challenges to securing air cargo. First, the explosives were difficult to detect using explosive detection equipment and canines. Second, questions were raised regarding the implementation and effectiveness of risk-based targeting methods to identify suspicious cargo. And third, the multiple international airports and air cargo facilities that served as intermediate transfer points illustrated the highly interconnected nature of the international air cargo industry, which necessitates close collaboration and coordination among governments, forwarders, air carriers, and airport operators to address security.

 

While we don’t want to assume this threat, the “Insider Threat” still presents a threat to air cargo security. While shippers may have limited ability to target a specific aircraft or even predict if an item will move on a passenger aircraft or an all-cargo aircraft, insiders working in the air cargo industry could use their access and knowledge to carry out an attack. The Congressional Research Service states, “Historically, in the United States, air cargo supply chains have been infiltrated by organized criminal elements conducting systematic theft and smuggling operations. Overseas, there is growing concern that terrorist networks could infiltrate airports and air cargo operations to gather information about possible weaknesses and exploit vulnerabilities in the supply chain.”

 

Lastly, theft is a very real concern in the supply chain, including the air cargo supply chain. While cargo is more vulnerable to theft when hauled by a truck, cargo theft gangs are seeking opportunities to steal cargo from airports as some items shipped by air tend to be high value items. According to Air Cargo Eye, in February 2017, thieves escaped with rare 15th and 16th century antique books valued at more than $2.3 million after they broke into a facility at London’s Heathrow Airport. In March 2017, thieves were seen masquerading as police officers while using what were reported as police vehicles intercepting a cargo of $1.7 million of banknotes shortly after the aircraft had arrived at Johannesburg’s OR Tambo International Airport.

 

transportation security administrationPreventing Air Cargo Threats

 

Whereas the air cargo industry has favored risk-based approaches for both cargo planes and cargo placed aboard passenger aircraft, some policymakers have argued that more comprehensive screening of cargo is needed to make cargo security comparable to the screening of airline passengers and baggage. The 9/11 Commission Act of 2007 required 100% physical screening and inspection of all cargo placed on passenger aircraft. Acceptable screening methods include x-ray systems, explosives detection systems, explosives trace detection, TSA-certified explosives detection canine teams, and physical searches conducted in conjunction with manifest verifications. Cargo documents and known shipper verification are not acceptable screening methods.

 

While TSA has approved a number of detection systems for screening air cargo to meet the requirements of the 100% screening mandate, none of these devices have been approved for the screening of palletized or containerized cargo. According to the Congressional Research Service, it is estimated that palletized cargo makes up 75% of all cargo carried on passenger planes. The lack of an approved technology for screening pallets leaves the industry dependent on work-around solutions, largely involving the off-airport screening of cargo combined with approved supply-chain security measures to prevent tampering after the item is screened.

 

In regard to air cargo theft, organizations can take the following actions to help prevent theft in the industry:

  1. Thoroughly screen prospective employees
  2. Carefully select transportation partners and intermediaries
  3. Provide security training within your organization
  4. Incorporate surveillance into the duties of security guards, and have guards patrol away from perimeters
  5. Leverage technology such as equipment tracking, security seals, or locks
  6. Periodically conduct security audits

 

In addition to the organizations themselves being involved, various supply chain security measures provide options for preventing and detecting tampering while maintaining the integrity of the shipment. These measures include tamper-evident and tamper-resistant packaging, cargo tracking technologies, and identifiers to designate screened cargo.

 

air cargo packages

 

 

Final Thoughts

 

Today, thousands of products are being delivered by air freight. This service has made it possible for people and organizations around the world to have the goods needed for everyday life. Several industries have been able to grow internationally due to air freight, although there are challenges faced along the way.

 

The industry still faces the challenge of security threats and how to combat them to ensure the safety of the product and passengers. Technology continues to advance to screen cargo for these threats, and technology advances even further to maintain product quality and safety aboard an aircraft. The Federal Aviation Administration (FAA) forecasts that steady U.S. and world economic growth will drive more modest annual increases of about 3% in air cargo shipments over the next two decades. Innovation, education, and due diligence will continue to help the industry combat air cargo security.

 

As the air cargo supply chain continues to grow, I hope this information was helpful in answering some of your questions regarding air cargo, security, safety, and product quality.

 

 

 

 

 

 

Cold Chain Council for what should be on your whiteboard for2020-2030

Prepare Your Cold Chain for the Next Decade

November 12th, 2019 Posted by Pharmaceutical & Life Sciences, Technology, Temperature Protection, Update 0 thoughts on “Prepare Your Cold Chain for the Next Decade”

The Cold Chain transportation experts at QProducts & Services present the 5 innovations you should include on your cold chain whiteboard for 2020-2030.

 

 

 

 

Our annual gathering of industry leaders at the Cold Chain Council for the Pharma & Chemical Industries took place October 1st, 2019 in Chicago, IL. As a result, attendees left armed with knowledge to help them strategically plan their cold chain operations for the next decade. Thus, there are many things going on socially, logistically, and environmentally to be aware of, from blockchain to medical drone deliveries.

 

In summary, here are the top 5 innovations to put on your cold chain whiteboard for 2020-2030:

 

 

Additional information and resources in regard to these technological innovations is below:

Drones

Drones that deliver blood and medical supplies are saving lives as they provide faster, efficient care by supplying medicine, pharmaceuticals, vaccines, and emergency medical equipment. Drone delivery has begun to disrupt both the transportation and pharmaceutical and medical industries as they allow improved access to medical supplies, especially in rural areas. Learn more about how drone delivery and drone technology is shaping the future of these industries. For further information on this topic, please visit the following resources:

  1. Drones in Healthcare
  2. What is Drone Delivery and How is it Changing the Pharmaceutical Supply Chain?
  3. Drones Delivering Medical Supplies and More Can Help Save American Lives

 

Blockchain

The pharmaceutical industry is actively exploring blockchain technology to help with the tracking and tracing of products, product provenance, and supply chain governance. Blockchain technology also provides the opportunity to decrease costs and increase transparency and trust during clinical trials. Blockchain technology could be a major solution to a $450 billion U.S. industry. Read more about how blockchain is revolutionizing the pharmaceutical and medical industry. For further information on this topic, please visit the following resources:

  1. How Blockchain Will Revolutionize the Pharmaceutical Industry
  2. Pharma Meets Blockchain – Solution to $450 Billion U.S. Industry
  3. Five Use Cases for Blockchain in Pharma

 

Augmented Reality (AR)

Augmented reality holds the ability to visualize production processes, which could help to improve pharmaceutical manufacturing. However, the value of augmented reality not only lies in manufacturing, but in patient outcomes as well. Augmented reality is now being used to help reduce patient pain and anxiety levels in patients without the need for additional medication. Learn more about how augmented reality is transforming these industries. For further information on this topic, please visit the following resources:

  1. The Future is Mixed Reality: Augmented Reality Put to Work on Manufacturing
  2. 8 Benefits of Virtual Reality in the Pharmaceutical Industry
  3. Augmented Reality in Healthcare Will Be Revolutionary

 

IoT – Internet of Things

The pharmaceutical and medical industry is perfectly positioned to benefit from IoT, or the Internet of Things. The data collected can have a significant impact on the production and administration of pharmaceuticals, while helping to smooth logistics, eradicate recalls, and improve operational efficiency. Learn more about the IoT and its impact on pharmaceutical and medical. For further information on this topic, please visit the following resources:

  1. How is IoT Transforming the Pharmaceutical Industry?
  2. How Can the Pharmaceutical Industry Benefit from the IoT?
  3. How IoT is Revolutionizing the Pharma Industry

 

QProducts & Services extends their gratitude to the many industry experts that spoke at our event.

Together, our speakers educated attendees on how to best leverage the latest innovations for their 2020-2030 cold chain operations.

 

QProducts & Services is a manufacturer of passive temperature protection and cargo security solutions for the global supply chain. For over 25 years, they have developed innovative, cost-saving solutions for transporting temperature sensitive commodities. QProducts & Services has expanded their product line to include cargo security solutions and wireless temperature monitoring technologies. Manufactured just outside of Chicago, IL, their patented products are noted for durability, performance and reliability in protecting the integrity of shippers’ cargo throughout the supply chain.

Cannabis Disruption in the Pharma & Chemical Industry

October 18th, 2019 Posted by Pharmaceutical & Life Sciences, Transportation 0 thoughts on “Cannabis Disruption in the Pharma & Chemical Industry”

Cannabis Disruption in the Pharmaceutical & Chemical Industry

Authors: QProducts & Services Pharma & Chemical Team, Under the Direction of Jim O’Donnell

 

 

 

 

The recent and continuous growth of the cannabis industry has attracted many businesses to join in on this lucrative and evolving space. With the recreational use of cannabis now legal in 11 states, and medical marijuana legal in 33 states, cannabis is on its way to possibly becoming an $80 billion industry by 2030, according to estimates by Cowen, Inc. The explosive growth of this space in a short period of time has created a need for a new era of supply chain management to help adapt to new regulations, distribution models, and other challenges related to a highly regulated but thriving industry, according to Green Entrepreneur. In the pharmaceutical and chemical industries specifically, we’re experiencing the continuous rise of medicinal marijuana and new insights for Big Pharma and its supply chain.

 

What is Cannabis?

Cannabis, also referred to as marijuana, comes from a group of three plants with psychoactive properties: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. When the flowers of these plants are harvested and dried, you’re left with cannabis, one of the most common drugs in the world. It is made up of more than 120 components, also known as cannabinoids, of which we can find cannabidiol (CBD) and tetrahydrocannabinol (THC). While THC is psychoactive, CBD is not, and you can find cannabis products that contain just CBD, THC, or a combination of both.

 

cannabis plant

Where Did CBD Come From?

 

Cannabidiol (CBD) is a compound extracted from hemp or marijuana. The 2018 Farm Bill excluded hemp from the definition of marijuana and removed it from the Controlled Substances Act (CSA).

 

CBD was first discovered by Dr. Roger Adams and his team at the University of Illinois in 1940, however, its structure was not made clear until 1963. While it may lead some to assume that CBD is a newly discovered ingredient, cannabis and CBD have a history that dates back thousands of years. According to CBD Origin, the first documented use of cannabis-derived medicine dates back to 2737 B.C. It can be said that Chinese Emperor Sheng Nung used a cannabis-infused tea to aid with a variety of ailments including memory, malaria, rheumatism, and gout. Throughout history, cannabis and CBD have been used for therapeutic purposes, however, during the rise of modern medicine, it was not recognized due to a lack of scientific evidence.

 

More recently, and with the legalization of medical marijuana, researchers have been prompted to dive more into CBD and its potential medicinal uses. While the stigma towards CBD and cannabis has changed over the last few decades in the United States, we are still in the early stages of research, legalization, and recreational use. However, with the federal legalization of hemp and hemp-derived CBD, more and more CBD products are being sold online by major retailers including Sephora and Neiman Marcus.

 

cbd oil

 

The Legalization of Hemp

 

The Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill, was signed on December 20th, 2018, and will remain in force through 2023. The passing of the 2018 Farm Bill allowed the legalization of hemp agriculture and products in all 50 U.S. states. In the United States, hemp plants are defined as any cannabis plant that has 0.3 percent or less THC. Any cannabis plant that has a THC content greater than 0.3 percent is classified as marijuana. From a chemical composition standpoint, hemp cannot get you high.

 

According to Analytical Cannabis, the increased legality of hemp is largely to thank for the rapid acceleration in diversity and availability of hemp-derived CBD oil. Unless you go to a marijuana dispensary to purchase CBD oil, the CBD oil that you find is made exclusively from the hemp plant, which is also referred to as hemp oil or CBD hemp oil. Since CBD can be extracted from hemp, CBD is legal. However, there is still work to be done when it comes to FDA regulation. According to a leader of the U.S. Food and Drug Administration’s new cannabinoid work group, there is more research to be done before federal authorities can allow CBD treatments into food and beverage products. Just like any other new ingredient going into food or drugs, the FDA is unlikely to approve over-the-counter use without further research on the ingredient and its health benefits. With that being said, certain companies with a loyal customer base are likely to wait until CBD is FDA approved prior to marketing CBD products to consumers. While FDA approval is in the works, fortune 500 companies are educating themselves on the evolving market, investing heavily, and laying the groundwork within their networks.

 

The History of Medicinal Cannabis

 

Medicinal cannabis, also referred to as medicinal marijuana, has been widely known for its use in medical treatments and therapy, which has garnered national attention in recent years. While evidence suggests cannabis use more than 5,000 years ago in what is now Romania, there is only one direct source of evidence that cannabis was first used medicinally around 400 A.D. In the U.S., cannabis was widely utilized as a patent medicine during the 19th and early 20th centuries. According to Medical Daily, in the late 1700s, some American medical journals were suggesting using hemp seeds and roots to treat various health problems, including skin inflammation and incontinence. William O’Shaughnessy was an Irish doctor in the British East India Company who touted medical marijuana’s benefits for rheumatism and nausea in England and America.

 

The Marijuana Tax Act was the very first federal restriction of cannabis use and cannabis sale, taking effect in 1937. Subsequent to the act of 1937, legal penalties for possession of the drug began to increase in 1951 and 1956 with the enactment of the Boggs and Narcotic Control Acts. In 1970, prohibition under Federal Law occurred with the Controlled Substances Act and marijuana was classified as a Schedule 1 drug. Then, in 1996, California became the first state to allow legal access to and use of cannabis for medicinal purposes under physician supervision with the enactment of the Compassionate Use Act. According to Business Insider, medical marijuana is legal in 33 states in 2019. Medical Daily also states that only people with certain qualifications can obtain the drug. That will usually entail children with epileptic conditions, or sometimes cancer patients who use cannabis to ease the side effects of chemotherapy or radiation. Some states allow patients with HIV/AIDS, Parkinson’s disease, multiple sclerosis, or even Chron’s disease to obtain medical cannabis.

 

pharmaceutical cannabis

 

The Rise of Medicinal Cannabis

 

As restrictions are lifted and research into medical cannabis continues, more recent research has started to explore more of its therapeutic benefits. For instance, a 2015 study found that cannabis could be effective in treating schizophrenia. In addition, research has shown that the drug can help stop severe seizures and even cure migraines.

 

According to Harvard Health, the most common use for medical marijuana in the United States is for pain control. While marijuana isn’t strong enough for severe pain (for example, post-surgical pain or a broken bone), it is quite effective for the chronic pain that plagues millions of Americans, especially as they age. In 2014, a survey conducted in California found that medical marijuana patients agree that the drug works as 92 percent of them said that medical marijuana alleviated symptoms of their serious medical conditions including chronic pain, arthritis, migraines, and cancer. According to WebMD, the number of registered U.S. medical marijuana patients rose from more than 641,000 in 2016 to nearly 814,000 in 2017. In states where medical marijuana is legal, there seems to be somewhat of a general consensus that it is helpful in treating a variety of ailments. However, for more serious conditions, pharmaceuticals remain a necessity for patients.

 

medicinal cannabis

 

Disruption Within the Pharmaceutical Industry

 

Marijuana’s growing availability, both recreationally and medically, is impacting the pharmaceutical industry in various ways. First, the cost of healthcare could decrease for people who use marijuana as a treatment. This could reduce healthcare costs for the rest of the U.S., as well. However, lower costs also means less profits for doctors, hospitals, and the pharmaceutical companies. The reduced need for pain medications or even mental health medications is a great example of the current disruption occurring within these industries. According to Health Care in America, on average, in states where medical cannabis is legal, doctors prescribe upwards of 260 fewer doses of antidepressants and 560 fewer doses of anxiety medication than in other states, per doctor. A survey of more than 1,300 U.S. cannabis consumers, conducted by JAMA Internal Medicine, found that about 80% had used marijuana as a substitute for pharmaceuticals, primarily opioids. As Green Thumb Industries stated, “Every day, more and more patients are opting to use it as a replacement to traditional prescription medications that may cause unwanted side effects.” This presents the opportunity for pharmaceutical companies to invest in the medical marijuana market to develop products or participate in research.

 

Second, it’s important to note that other drug companies are starting to invest more time and money in cannabis research now that 33 states and the District of Columbia allow medical marijuana. For example, the pharmaceutical industry has sponsored more than 120 federal clinical trials involving cannabinoids, or chemicals that are unique to the marijuana plant. Additionally, GW Pharmaceuticals recently received federal approval for the epilepsy treatment Epidiolex, the first prescription drug derived from cannabis. Also, the Canadian marijuana company, Tilray, announced in December 2018 that they have signed an agreement to partner with Novartis subsidiary, Sandoz, to sell medical marijuana in countries where it is legal.

 

According to Investor’s Business Daily, companies ranging from small biotech stocks to giant pharma companies such as AbbVie are exploring cannabis medicine and what products can be derived from it. Many companies are in the startup phase, but hundreds of studies are underway on possible uses for cannabis. Additional companies working in cannabis medicine that are studying laboratory-created cannabinoids include Cara Therapeutics, Corbus Pharmaceuticals, Insys Therapeutics, and Zynerba Pharmaceuticals.

scientist measuring cannabis Challenges in the Supply Chain

 

In the U.S., California’s market is by far the largest in both geography and in the number of users regarding the cannabis industry. California distributors believe that they can develop reliable logistics to support the current cannabis market that would solve challenges across other regions, should cannabis become legal at the federal level. Currently, the nation faces the challenge of cannabis distribution as federal laws currently prohibit the transportation of cannabis across state lines. Because cannabis is illegal at the federal level, freight trucks that are regulated by the Department of Transportation are unable to carry cannabis. In addition to logistics operations, the cannabis industry still faces the stigma against the trade and the challenges that come with financial transactions as well.

 

As for medical marijuana, the same restrictions apply as medical marijuana is not yet legal in all 50 U.S. states. Changing national laws will make it easier to work with the cannabis industry in states where it is legalized, but the real breakthrough will be full, nationwide legalization that allows for interstate commerce.

 

pharmaceutical supply chain

 

Final Thoughts

 

The legalization of medicinal marijuana presents both opportunities and challenges for the pharmaceutical and chemical industry. For many pharmaceutical companies, the chance to service a market with predictable high margins is definitely a growth factor. If and when cannabis is removed from its Schedule 1 status, the flood-gates are expected to open even further.

 

As cannabis continues to have an impact on the pharmaceutical and chemical industry, I hope this information was helpful in answering some of your questions regarding the rise of medicinal marijuana and how it is expected to impact these industries.

What’s On Your Supply Chain White Board for 2020?

September 9th, 2019 Posted by Pharmaceutical & Life Sciences, Technology, Update 0 thoughts on “What’s On Your Supply Chain White Board for 2020?”

Top pharma executives and supply-chain tech experts to gather in Chicago for 4th Annual Cold Chain Council meeting


 

 

 

 

October 1st in Chicago’s’ Museum Campus district will mark the 4th Cold Chain Council for the pharma, healthcare and chemical industries. This educational forum will feature panel discussions and presentations by top executives and tech experts discussing the new decade ahead, trends in supply chain tech and best practices for 2020.

 

With a key focus on furthering the industry and advancing best practices in the supply chain and cold chain respectively, the main goal of the Cold Chain Council is to bring together high-level industry professionals to share in thought leadership and create a casual platform for discussion of real world challenges and solutions derived from everyday experiences of speakers and attendees alike. Hosted by QProducts & Services, there are no other sponsors, no fee to attend, and attendance is capped to provide an informal and informative feel for one afternoon in Chicago.

 

Amy ShortmanThis year’s event will be moderated by Amy Shortman, a senior executive at Overhaul Group. Her keynote will set the scene for the day’s discussion on how technology will affect traditional supply chains, the scope of our working environment and the benefits that may arise. Amy’s expertise stems from more than twenty years of pharmaceutical logistics experience. A Chartered Fellow of The Institute of Transport and Logistics, Amy has become a well-known thought leader in education and brand awareness to the healthcare and logistics industry’s need for improved compliance and cool chain management, backed by her professional career including roles in operations for a global logistics provider of clinical trials, a world-leading temp-controlled container company, supply chain security for a “Top 3” third-party logistics provider and eventually establishing a global supply chain business services company, ASC Associates Ltd, specializing in high-value and temp-sensitive freight.

 

(for Amy Shortman’s full bio click here)

 

Amy will be in good company with an impressive line-up of industry experts hailing from a diverse group of companies: Big Pharma shippers AbbVie and McKesson; the World Federation of Hemophilia; computer-aided environment-software developer Smart CAE; smart technology manufacturers SensorTransport Inc and Berlinger USA; and advanced predictive risk-analysis software developer Riskpulse. Session topics have been locked in and speakers are teaming up to lead discussions in what promises to be an informative afternoon of interactive discussion and networking. The setting overlooks Chicago’s museums and lake front to the East and impressive skyline and Grant Park to the North. Here’s a taste of the agenda and talented roster:

 

Session One: Wild Weather and Adapting to The New Norm. Lane Analysis and Risk Visibility Through Advanced Forecasting and Data Analytics. Mark Russo, SVP of Weather Operations, Riskpulse

 

Session Two: Cold Chain Tech 2020. Service, Equipment and Qualification Innovations for The New Decade.
Stefan Braun, Managing Director, Smart CAE and Stephen Dusel, Sales Manager North, Berlinger USA

 

Session Three: Big Pharma Cold Chain Report. What’s New as We Look Ahead into The Twenties?
David Ulrich, QA Director of Global Supply Chain Compliance, Abbvie and Georgios Ampartzidis, Logistics Manager-Humanitarian Aid, World Federation of Hemophilia

 

Session Four: Digitization and IoT’s Continuing Impact on the Supply Chain. Michael Dee, VP of Global Security, McKesson; Amy Shortman, Director of Product Marketing, Overhaul Group Inc.; and Sascha Peyer, Co-Founder and CCO, SensorTransport, Inc.

(Full event details here)

Cold Chain Council Chicago

 

The afternoons’ sessions conclude with an interactive discussion between attendees and speakers, including an opportunity for Q&A before wrapping up and moving on to the evenings festivities.

 

The networking portion of the Cold Chain Council agenda includes cocktails and dinner reception at the Chicago Yacht Club followed by a private yacht cruise down the Chicago River at nightfall.

 

 

 

For more information on content and key takeaways from this event, connect with event hosts QProducts & Services on LinkedIn or visit the Cold Chain Council homepage for other CCC events and an opportunity to attend.

Cargo Containers in an ocean port

Making the Switch from Air to Ocean

September 18th, 2018 Posted by Air, Pharmaceutical & Life Sciences, Temperature Protection, Transportation 0 thoughts on “Making the Switch from Air to Ocean”

Value of Thermal Blankets Verified as an Integral Part of the Transition from Air to Ocean

Think of a question? Want to learn more?
q products and services logo

If you're searching for thermal shipping, insulated shipping containers, pallet wraps, thermal blankets, insulated foil, banana blankets, tote covers, drum covers, thermal blankets, shipping blankets, electronic cargo locks, or ice cream bags, you found all that and a whole lot more. We are fully committed to providing a passive thermal solution from top to bottom, nose to rear, of your temperature sensitive cargo.

Contact Us

16720 Mozart Ave.
Hazel Crest, IL 60429

© 2019 QProducts & Services